Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

Europe - EBR:EKOP - BE0974380124 - Common Stock

4.93 EUR
+0.09 (+1.86%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

1

Overall EKOP gets a fundamental rating of 1 out of 10. We evaluated EKOP against 42 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of EKOP have multiple concerns. EKOP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

EKOP had negative earnings in the past year.
EKOP had a negative operating cash flow in the past year.
In the past 5 years EKOP always reported negative net income.
EKOP had negative operating cash flow in 4 of the past 5 years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

EKOP's Return On Assets of -7.84% is on the low side compared to the rest of the industry. EKOP is outperformed by 71.43% of its industry peers.
The Return On Equity of EKOP (-29.69%) is worse than 73.81% of its industry peers.
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROIC N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

Looking at the Gross Margin, with a value of 30.21%, EKOP is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of EKOP has declined.
EKOP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

0

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EKOP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for EKOP has been increased compared to 5 years ago.
EKOP has a worse debt/assets ratio than last year.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that EKOP is in the distress zone and has some risk of bankruptcy.
EKOP has a Altman-Z score of 0.21. This is in the lower half of the industry: EKOP underperforms 71.43% of its industry peers.
EKOP has a Debt/Equity ratio of 1.30. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.30, EKOP is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC6.01%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

EKOP has a Current Ratio of 0.80. This is a bad value and indicates that EKOP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EKOP (0.80) is worse than 76.19% of its industry peers.
A Quick Ratio of 0.64 indicates that EKOP may have some problems paying its short term obligations.
EKOP's Quick ratio of 0.64 is on the low side compared to the rest of the industry. EKOP is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.64
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

EKOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -236.04%.
Looking at the last year, EKOP shows a very negative growth in Revenue. The Revenue has decreased by -32.41% in the last year.
EKOP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.09% yearly.
EPS 1Y (TTM)-236.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.69%
Revenue 1Y (TTM)-32.41%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-33.44%

3.2 Future

The Earnings Per Share is expected to grow by 60.98% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 25.77% on average over the next years. This is a very strong growth
EPS Next Y-81.63%
EPS Next 2Y14.29%
EPS Next 3Y24.69%
EPS Next 5Y60.98%
Revenue Next Year25.15%
Revenue Next 2Y23.27%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EKOP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EKOP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as EKOP's earnings are expected to grow with 24.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.29%
EPS Next 3Y24.69%

0

5. Dividend

5.1 Amount

No dividends for EKOP!.
Industry RankSector Rank
Dividend Yield N/A

EKOPAK NV

EBR:EKOP (9/26/2025, 7:00:00 PM)

4.93

+0.09 (+1.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)09-01 2025-09-01
Earnings (Next)11-04 2025-11-04/amc
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners82.57%
Ins Owner ChangeN/A
Market Cap86.28M
Analysts77.78
Price Target5.61 (13.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.8%
PT rev (3m)2.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-134.21%
EPS NY rev (3m)-317.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.81
P/FCF N/A
P/OCF N/A
P/B 2.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.09
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS2.72
BVpS2.35
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.84%
ROE -29.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.21%
FCFM N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 351.32%
Cap/Sales 57.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.64
Altman-Z 0.21
F-Score2
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)366.86%
Cap/Depr(5y)479.35%
Cap/Sales(3y)50.41%
Cap/Sales(5y)51.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.69%
EPS Next Y-81.63%
EPS Next 2Y14.29%
EPS Next 3Y24.69%
EPS Next 5Y60.98%
Revenue 1Y (TTM)-32.41%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-33.44%
Revenue Next Year25.15%
Revenue Next 2Y23.27%
Revenue Next 3Y16.96%
Revenue Next 5Y25.77%
EBIT growth 1Y-284%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.18%
EBIT Next 3Y159.4%
EBIT Next 5Y140.21%
FCF growth 1Y-159.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-474.52%
OCF growth 3YN/A
OCF growth 5YN/A